Aa Aa Aa

Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines to meet the major unmet medical needs of patients on a global basis.

Find out more.


  • January 21, 2015

    Robert J. Spiegel, M.D., FACP Joins Sucampo’s Board of Directors

  • December 30, 2014

    Sucampo Announces Acceptance of New Drug Submission for AMITIZA(R) (lubiprostone) by Health Canada

  • December 15, 2014

    Sucampo Appoints John H. Johnson to Board of Directors

  • November 25, 2014

    Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 26th Annual Piper Jaffray Healthcare Conference